Background: Intracoronary near-infrared spectroscopy (NIRS) in ST-segment elevation myocardial infarction (STEMI) has demonstrated substantial lipid in STEMI culprit plaques. Thrombus aspiration during PPCI reduces distal embolization and improves reperfusion. This study was performed to examine if thrombectomy reduces the lipid in STEMI culprit plaques. Methods: NIRS-IVUS imaging was performed in STEMI patients at two hospitals in the US and Sweden. After establishment of TIMI 3 flow with an undersized balloon, NIRS was performed, followed by aspiration thrombectomy, followed by repeated NIRS. The culprit lipid content was quantified before and after thrombectomy as the lipid core burden index (LCBI). Aspirates were examined with histology. Results: In 13 STEMI patients (age 64 AE 10, 69% male), culprit lesions were characterized by high lipid content prior to aspiration thrombectomy (LCBI 456AE145). Thrombectomy resulted in a 35% reduction in culprit lesion lipid content (LCBI pre 456AE145 vs post 296AE150, p<0.002). Histological analyzes of aspirates demonstrated thrombus plus lipid, calcium and macrophages, indicating that parts of atherosclerotic plaques had been aspirated. Conclusions: Thrombectomy in STEMI aspirates both thrombus and parts of the culprit atherosclerotic plaque, thereby reducing material which may embolize during stenting. Reduction of lipid content before stenting might contribute to the beneficial effects of thrombectomy and be particularly useful if a large lipid core is present at the culprit site. Background: Lumen loss and significant qualitative plaque changes, particularly increase in fibro-fatty tissue components, have been demonstrated at the edges of metallic DES. Polymeric bioresorbable scaffolds (BRS) have different biological behavior in comparison to metallic stents. In this study, we sought to investigate the vascular responses at the edges of the DESolve PLLA-based novolimus-eluting BRS. Methods: The DESolve NX study enrolled 126 pts treated with the DESolve BRS. Six-month invasive OCT was performed in 40 pts. Serial (baseline and 6 months) OCT images were available for 38 pts. Quantitative and qualitative changes in the 5-mm distal and proximal scaffold edges were examined by OCT at 0.6-mm interval. Results: Overall, 37/38 (97.4%) distal and 34/38 (89.5%) proximal edges had suitable serial OCT images for analysis. No significant changes were observed in lumen areas at both distal (D lumen area: -0.32AE8.14%; 95% CI: -2.44 to 2.56, p¼0.671) and proximal (D lumen area: -3.03AE12.12%; 95% CI: -7.21 to 1.50, p¼0.085) edges up to 6 months. At baseline, lipid-rich plaques were seen in 17 (23.9%) of the total 71 analyzed edges [4/37 (5.6%) at distal and 13/34 (38.2%) at proximal edges], and were still evident at 6 months. However, significant reductions in the longitudinal (-0.57AE0.79 mm; 95% CI: -0.97 to -0.16, p¼0.006) and circumferential .01 degrees; 95% CI: -30.07 to -11.55, p¼0.001) distribution of lipid plaques were observed from baseline to 6 months. Furthermore, a significant increase in mean fibrous cap (FC) In diabetes mellitus (DM), circulation number and function of endothelial progenitor cells are reduced. Therefore, we investigated the impact of DM for stent coverage on follow-up optical coherence tomography (OCT) image. Methods: From the OCT registry database, 153 patients (212 lesions, 53 DM patients with 66 lesions) who underwent follow up OCT at 3, 6, 9 or 12 months after sirolimus eluting stent implantation were analyzed. The percentage of uncovered or malapposed struts, intraluminal thrombus and the thickness of neointimal hyperplasia in every 1mm slice of the entire stent length, respectively, was compared between DM and non-DM patients group. Results: The mean percentages of uncovered strut were higher in lesions of DM patients than in that of non-DM patients (29.6 AE 29.7% vs. 20.9 AE 11.9% at 3 months, 23.3 AE 25.9% vs. 20.8 AE 18.9%, p¼0.731 at 6 months, 14.7 AE 10.8% vs. 8.4 AE 11.3% at 9 months and 11.8 AE17.3% vs. 4.7 AE 6.4% at 12 months) at every follow up OCT, but the difference was only significant at 9 months follow up (p¼0.026). The mean neointimal hyperplasia thickness, the percentage of malapposed struts and the incidence of intracoronary thrombus were not different between two groups at every follow up.
Background: Intracoronary near-infrared spectroscopy (NIRS) in ST-segment elevation myocardial infarction (STEMI) has demonstrated substantial lipid in STEMI culprit plaques. Thrombus aspiration during PPCI reduces distal embolization and improves reperfusion. This study was performed to examine if thrombectomy reduces the lipid in STEMI culprit plaques. Methods: NIRS-IVUS imaging was performed in STEMI patients at two hospitals in the US and Sweden. After establishment of TIMI 3 flow with an undersized balloon, NIRS was performed, followed by aspiration thrombectomy, followed by repeated NIRS. The culprit lipid content was quantified before and after thrombectomy as the lipid core burden index (LCBI). Aspirates were examined with histology. Results: In 13 STEMI patients (age 64 AE 10, 69% male), culprit lesions were characterized by high lipid content prior to aspiration thrombectomy (LCBI 456AE145). Thrombectomy resulted in a 35% reduction in culprit lesion lipid content (LCBI pre 456AE145 vs post 296AE150, p<0.002). Histological analyzes of aspirates demonstrated thrombus plus lipid, calcium and macrophages, indicating that parts of atherosclerotic plaques had been aspirated. Conclusions: Thrombectomy in STEMI aspirates both thrombus and parts of the culprit atherosclerotic plaque, thereby reducing material which may embolize during stenting. Reduction of lipid content before stenting might contribute to the beneficial effects of thrombectomy and be particularly useful if a large lipid core is present at the culprit site. In diabetes mellitus (DM), circulation number and function of endothelial progenitor cells are reduced. Therefore, we investigated the impact of DM for stent coverage on follow-up optical coherence tomography (OCT) image. Methods: From the OCT registry database, 153 patients (212 lesions, 53 DM patients with 66 lesions) who underwent follow up OCT at 3, 6, 9 or 12 months after sirolimus eluting stent implantation were analyzed. The percentage of uncovered or malapposed struts, intraluminal thrombus and the thickness of neointimal hyperplasia in every 1mm slice of the entire stent length, respectively, was compared between DM and non-DM patients group. Results: The mean percentages of uncovered strut were higher in lesions of DM patients than in that of non-DM patients (29.6 AE 29.7% vs. 20.9 AE 11.9% at 3 months, 23.3 AE 25.9% vs. 20.8 AE 18.9%, p¼0.731 at 6 months, 14.7 AE 10.8% vs. 8.4 AE 11.3% at 9 months and 11.8 AE17.3% vs. 4.7 AE 6.4% at 12 months) at every follow up OCT, but the difference was only significant at 9 months follow up (p¼0.026). The mean neointimal hyperplasia thickness, the percentage of malapposed struts and the incidence of intracoronary thrombus were not different between two groups at every follow up.
Conclusions: This study demonstrated that vascular healing after sirolimus-eluting stent implantation might be delayed in DM patients compared to non-DM patients New-Tokyo Hospital, Japan, Matsudo, Japan Background: Occlusion of SB after MB stent implantation is a potential concern during percutaneous coronary intervention (PCI) of coronary bifurcations as it might require additional procedures (i.e., guidewire crossing, balloon dilatation, and www.jacctctabstracts2013.com TUESDAY, OCTOBER 29, 2013, 3:30 PM-5:30 PM eventually additional stent implantation in SB ostium) while leading to ischemic compromise. Nevertheless, there is little data using FD-OCT imaging to better understand the relationship between underlying plaque and acute stent-vessel interactions in this setting.We aim to evaluate, by means frequency-domain optical coherence tomography (FD-OCT), the impact of main branch (MB) calcified plaques on side branch (SB) occlusion after MB stent implantation in coronary bifurcations. Methods: We evaluated 78 patients with native de novo coronary bifurcation lesions with SB deserving wire protection (side-branch length greater than 50mm) who underwent MB FD-OCT before stent implantation. FD-OCT assessments were performed pre-PCI to evaluate the plaque type calcium and non-calcium (fibrous and lipid) of main branch. SB occlusion was defined as % diameter stenosis greater than 75% of SB ostium by angiogram after MB stent implantation. Results: Occlusion of SB occurred in 43.6%-while 18 patients required balloon angioplasty for SB occlusion. In multivariable analysis, true bifurcation (odds ratio [OR]: 3.70; 95% confidence interval [CI]: 1.13 to 12.58; p ¼ 0.030) and calcified plaque determined by FD-OCT assessments (OR: 17.11; 95% CI: 4.97 to 58.96; p < 0.001) were independent predictors of SB occlusion. Conclusions: Calcified plaque demonstrated by FD-OCT assessments as well as true bifurcations were identified as independent predictors of SB occlusion after MB stent implantation.
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Optical coherence tomography during everolimus-eluting bioabsorbable vascular scaffold implantation in patients whith acute coronary syndrome. Background: Everolimus-eluting bioabsorbable vascular scaffold (BVS) is a new promising therapeutic technology for the treatment of coronary heart disease. However, clinical experience with this device is still limited in patients with acute coronary syndrome and thrombus containing lesions. The purpose of this study is to analyze the usefulness of the optical coherence tomography (OCT) in the monitorization of these procedures. Methods: From January 2012 to May 2013, 66 patients with acute coronary syndrome were treated by BVS implantation. After identification of the culprit lesion, a baseline intravascular ultrasound study (IVUS) was performed. Taking into consideration the IVUS information, direct stent deployment was carried out in 44 patients (67%). After the BVS implantation, an OCT catheter was advanced distal to the area of interest over a conventional coronary guide-wire. Several pullbacks were performed to obtain an optimal visualization of the treated segment. Results: The mean age was 55AE9 years, 25 (38%) patients had ST elevation and the remaining 41 had ACS without ST elevation. After treatment, the percentage of stenosis changed from 81AE15% to 6AE6%. According with the angiographic criteria, the procedure was successful in all 66 patients. However, immediately after the BVS deployment the OCT showed the following negative findings: 1) Proximal struts non apposition 13 (20%). 2) Distal struts non apposition 3 (4%). 3) Prolapse of the plaque or thrombus into the BVS 24 (36%). 4) Proximal edge dissection (non-detected by angiography) 8 (12%). 5) Distal edge dissection (non-detected by angiography) 10 (15%). 6) Severe BVS under-expansion 4 (6%). 7) Main vessel BVS deformation after side branch dilation 4 (out of 10 treated bifurcation lesions). According with these findings the operator modified the procedural strategy in 36 patients (54%): 1) Postdilation of the BVS with a new balloon in 28 (42%). 2) Kissing balloon or sequential dilation (side-main-side) in 4 bifurcation lesions. There were no in-hospital major complications. Conclusions: Angiography has limitations in the assessment of the immediate results after BVS treatment of coronary lesions. However, OCT is an useful adjunctive tool during the monitorization of this procedure in patients with acute coronary syndromes. Background: Atherosclerosis is a systemic inflammatory disease involving multiple arterial beds. Despite differences in the carotid and coronary vasculature, both vascular distributions are believed to share common pathway in disease progression. It is not known whether the atherosclerotic plaque composition is associated with stent restenosis and atherosclerosis progression. Methods: In Latvian Center of Cardiology patients for previous indications underwent coronary and carotid angiography. Patients with concomitant coronary and carotid artery disease defined as !50 % stenosis were included in single-center, prospective study. All patients were scheduled for carotid and/or coronary artery stenting and prior to intervention IVUS-VH (Eagle Eye; Volcano Therapeutics Inc; CA, USA) imaging of coronary and carotid plaque were done. Angiography and IVUS-VH follow-up was scheduled after 16 month. Results: 100 consecutive patients (60% men), mean age 69.6AE8.4 years, were enrolled. 78.0% of patients (n¼78) underwent carotid stenting and 36.0% (n¼36) had PCI. For 75 patients angiographic and IVUS-VH follow-up was done (mean 489 days, 95% CI 507.0 -631.8). Carotid restenosis rate was 1.8% (n¼1). 3 of 17 patients (17.6%) had plaque progression and consequent carotid stenting. Coronary restenosis rate was 25.8% (8 of 31 patients). We found no difference in unstented carotid plaque tissue composition by IVUS-VH at baseline between progressive (n¼3) and nonprogressive (n¼14) carotid plaques (fibrotic tissue 56.7AE8.4% vs 57.3AE7.4%, p¼0.898, fibrolipids 15.0AE7.5% vs 18.7AE9.3%, p¼0.531, calcium 5.7AE3.5% vs 5.8AE4.0%, p¼0.959, necrotic core 22.3AE12.9% vs 18.4AE9.7%, p¼0.548). Similarly, no association with IVUS-VH characteristics of culprit lesion at baseline was found between coronary restenosis (n¼8) and no-restenosis (n¼23) group. Conclusions: Atherosclerotic plaque tissue characteristics by IVUS-VH were not associated with carotid plaque progression and frequency of restenosis in coronary arteries in these series. Restenosis rate in carotid arteries is low in comparison with coronary arteries regardless of the stenosis morphological differences.
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